SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-008857 to Nakamoto Inc. (NAKA)

Nakamoto Inc.
Date: Aug. 14, 2023 · CIK: 0001946573 · Accession: 0000000000-23-008857

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
August 14, 2023
Author
Not clearly detected
Form
UPLOAD
Company
Nakamoto Inc.

Letter

United States securities and exchange commission logo August 14, 2023 Timothy Pickett Chief Executive Officer Kindly MD, Inc. 230 W 400 South Suite 201 Salt Lake City, UT 84104 Re:Kindly MD, Inc. Amendment No. 2 to Draft Registration Statement on Form S-1 Submitted July 26, 2023 CIK No. 0001946573 Dear Timothy Pickett: We have reviewed your amended draft registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to these comments and your amended draft registration statement or filed registration statement, we may have additional comments. Amendment No. 2 to Draft Registration Statement on Form S-1 Plan of Operation , page 35 1.We note your response to previous comment 13 and re-issue the comment in part. In your description of your 2023 operational plan, you note that "[a]t present, [y]our operations are solely based in Utah and [you] have not currently targeted or planned specific expansion into other states." However, your disclosure also states that you "hope to be able to enter four new markets in the twelve calendar months following the closing of the Offering." We also note that your Growth Strategy section on page 5 of the Prospectus states that "[t]he markets that [you] intend to explore and evaluate include North Carolina, Texas, Florida, Pennsylvania, among further expansion in Utah." Please reconcile your

FirstName LastNameTimothy Pickett Comapany NameKindly MD, Inc. August 14, 2023 Page 2 FirstName LastName Timothy Pickett Kindly MD, Inc. August 14, 2023 Page 2 disclosure regarding your twelve calendar month timeline and intended exploration of those specific markets with your statement that you have not currently targeted or planned specific expansion into other states. Government Regulation, page 42 2.We note your response to previous comment 13 and we refer you to our comment above. We note your current growth plans and your disclosure that you hope to be able to enter four new markets in the twelve calendar months following the closing of the Offering. Please revise to clarify your disclosures and include the appropriate regulatory disclosures in this section if you elect to include disclosures regarding your entry into the new four markets. As appropriate, revise to include risk factor disclosures regarding the uncertainty of entering into these markers. You may contact Julie Sherman at 202-551-3640 or Al Pavot at 202-551-3738 if you have questions regarding comments on the financial statements and related matters. Please contact Conlon Danberg at 202-551-4466 or Lauren Nguyen at 202-551-3642 with any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Callie Tempest Jones, Esq.

Show Raw Text
United States securities and exchange commission logo
August 14, 2023
Timothy Pickett
Chief Executive Officer
Kindly MD, Inc.
230 W 400 South
Suite 201
Salt Lake City, UT 84104
Re:Kindly MD, Inc.
Amendment No. 2 to Draft Registration Statement on Form S-1
Submitted July 26, 2023
CIK No. 0001946573
Dear Timothy Pickett:
            We have reviewed your amended draft registration statement and have the following
comments.  In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
            Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR.  If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
            After reviewing the information you provide in response to these comments and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Amendment No. 2 to Draft Registration Statement on Form S-1
Plan of Operation , page 35
1.We note your response to previous comment 13 and re-issue the comment in part. In your
description of your 2023 operational plan, you note that "[a]t present, [y]our operations
are solely based in Utah and [you] have not currently targeted or planned specific
expansion into other states." However, your disclosure also states that you "hope to be
able to enter four new markets in the twelve calendar months following the closing of the
Offering." We also note that your Growth Strategy section on page 5 of the Prospectus
states that "[t]he markets that [you] intend to explore and evaluate include North Carolina,
Texas, Florida, Pennsylvania, among further expansion in Utah." Please reconcile your

 FirstName LastNameTimothy  Pickett
 Comapany NameKindly MD, Inc.
 August 14, 2023 Page 2
 FirstName LastName
Timothy  Pickett
Kindly MD, Inc.
August 14, 2023
Page 2
disclosure regarding your twelve calendar month timeline and intended exploration of
those specific markets with your statement that you have not currently targeted or planned
specific expansion into other states.
Government Regulation, page 42
2.We note your response to previous comment 13 and we refer you to our comment
above. We note your current growth plans and your disclosure that you hope to be able to
enter four new markets in the twelve calendar months following the closing of the
Offering. Please revise to clarify your disclosures and include the appropriate regulatory
disclosures in this section if you elect to include disclosures regarding your entry into the
new four markets. As appropriate, revise to include risk factor disclosures regarding the
uncertainty of entering into these markers.
            You may contact Julie Sherman at 202-551-3640 or Al Pavot at 202-551-3738 if you
have questions regarding comments on the financial statements and related matters.  Please
contact Conlon Danberg at 202-551-4466 or Lauren Nguyen at 202-551-3642 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Callie Tempest Jones, Esq.